nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Imiquimod—skin cancer	0.269	0.452	CbGbCtD
Triamterene—CYP1A2—Vemurafenib—skin cancer	0.147	0.248	CbGbCtD
Triamterene—CYP1A2—Dacarbazine—skin cancer	0.113	0.19	CbGbCtD
Triamterene—SCNN1D—nose—skin cancer	0.0805	0.291	CbGeAlD
Triamterene—CYP1A2—Fluorouracil—skin cancer	0.0662	0.111	CbGbCtD
Triamterene—SCNN1A—nose—skin cancer	0.0628	0.227	CbGeAlD
Triamterene—SCNN1A—hair follicle—skin cancer	0.0151	0.0545	CbGeAlD
Triamterene—Azotaemia—Vismodegib—skin cancer	0.0147	0.129	CcSEcCtD
Triamterene—Lamotrigine—SCN10A—skin cancer	0.0145	1	CrCbGaD
Triamterene—SCNN1G—nipple—skin cancer	0.0131	0.0474	CbGeAlD
Triamterene—SCNN1B—nipple—skin cancer	0.0111	0.04	CbGeAlD
Triamterene—SCNN1D—epithelium—skin cancer	0.00881	0.0319	CbGeAlD
Triamterene—SCNN1G—mammalian vulva—skin cancer	0.00764	0.0277	CbGeAlD
Triamterene—SCNN1B—epithelium—skin cancer	0.00745	0.027	CbGeAlD
Triamterene—Blood urea increased—Vismodegib—skin cancer	0.00739	0.065	CcSEcCtD
Triamterene—SCNN1A—epithelium—skin cancer	0.00688	0.0249	CbGeAlD
Triamterene—SCNN1D—female reproductive system—skin cancer	0.00655	0.0237	CbGeAlD
Triamterene—SCNN1G—female reproductive system—skin cancer	0.00655	0.0237	CbGeAlD
Triamterene—SCNN1B—mammalian vulva—skin cancer	0.00646	0.0234	CbGeAlD
Triamterene—SCNN1A—mammalian vulva—skin cancer	0.00597	0.0216	CbGeAlD
Triamterene—SCNN1B—female reproductive system—skin cancer	0.00553	0.02	CbGeAlD
Triamterene—SCNN1D—head—skin cancer	0.00547	0.0198	CbGeAlD
Triamterene—Hypokalaemia—Vismodegib—skin cancer	0.00517	0.0455	CcSEcCtD
Triamterene—SCNN1A—female reproductive system—skin cancer	0.00511	0.0185	CbGeAlD
Triamterene—SCNN1B—head—skin cancer	0.00462	0.0167	CbGeAlD
Triamterene—SCNN1A—head—skin cancer	0.00427	0.0155	CbGeAlD
Triamterene—Photosensitivity—Vemurafenib—skin cancer	0.004	0.0351	CcSEcCtD
Triamterene—SCNN1D—lymph node—skin cancer	0.00383	0.0139	CbGeAlD
Triamterene—SCNN1B—lymph node—skin cancer	0.00324	0.0117	CbGeAlD
Triamterene—SCNN1A—lymph node—skin cancer	0.00299	0.0108	CbGeAlD
Triamterene—Photosensitivity reaction—Vemurafenib—skin cancer	0.00277	0.0243	CcSEcCtD
Triamterene—CYP1A2—nipple—skin cancer	0.00245	0.00888	CbGeAlD
Triamterene—Fatigue—Vismodegib—skin cancer	0.00241	0.0212	CcSEcCtD
Triamterene—Photosensitivity reaction—Imiquimod—skin cancer	0.00236	0.0208	CcSEcCtD
Triamterene—Asthenia—Vismodegib—skin cancer	0.002	0.0176	CcSEcCtD
Triamterene—Diarrhoea—Vismodegib—skin cancer	0.00191	0.0168	CcSEcCtD
Triamterene—Photosensitivity—Fluorouracil—skin cancer	0.00188	0.0165	CcSEcCtD
Triamterene—Vomiting—Vismodegib—skin cancer	0.00178	0.0156	CcSEcCtD
Triamterene—Rash—Vismodegib—skin cancer	0.00176	0.0155	CcSEcCtD
Triamterene—Dermatitis—Vismodegib—skin cancer	0.00176	0.0155	CcSEcCtD
Triamterene—Anaphylactic shock—Vemurafenib—skin cancer	0.00173	0.0152	CcSEcCtD
Triamterene—Nausea—Vismodegib—skin cancer	0.00166	0.0146	CcSEcCtD
Triamterene—Hypokalaemia—Temozolomide—skin cancer	0.00163	0.0144	CcSEcCtD
Triamterene—Dry mouth—Imiquimod—skin cancer	0.0015	0.0132	CcSEcCtD
Triamterene—Fatigue—Vemurafenib—skin cancer	0.00149	0.0131	CcSEcCtD
Triamterene—Photosensitivity reaction—Temozolomide—skin cancer	0.00142	0.0124	CcSEcCtD
Triamterene—Photosensitivity reaction—Fluorouracil—skin cancer	0.0013	0.0115	CcSEcCtD
Triamterene—Hypersensitivity—Vemurafenib—skin cancer	0.00127	0.0112	CcSEcCtD
Triamterene—Fatigue—Imiquimod—skin cancer	0.00127	0.0112	CcSEcCtD
Triamterene—Asthenia—Vemurafenib—skin cancer	0.00124	0.0109	CcSEcCtD
Triamterene—Diarrhoea—Vemurafenib—skin cancer	0.00118	0.0104	CcSEcCtD
Triamterene—Dizziness—Vemurafenib—skin cancer	0.00114	0.01	CcSEcCtD
Triamterene—Vomiting—Vemurafenib—skin cancer	0.0011	0.00964	CcSEcCtD
Triamterene—Rash—Vemurafenib—skin cancer	0.00109	0.00956	CcSEcCtD
Triamterene—Dermatitis—Vemurafenib—skin cancer	0.00109	0.00955	CcSEcCtD
Triamterene—Hypersensitivity—Imiquimod—skin cancer	0.00108	0.00953	CcSEcCtD
Triamterene—Headache—Vemurafenib—skin cancer	0.00108	0.0095	CcSEcCtD
Triamterene—Asthenia—Imiquimod—skin cancer	0.00106	0.00928	CcSEcCtD
Triamterene—Anaphylactic shock—Bleomycin—skin cancer	0.00105	0.00919	CcSEcCtD
Triamterene—Nausea—Vemurafenib—skin cancer	0.00103	0.00901	CcSEcCtD
Triamterene—Thrombocytopenia—Bleomycin—skin cancer	0.00102	0.009	CcSEcCtD
Triamterene—Diarrhoea—Imiquimod—skin cancer	0.00101	0.00885	CcSEcCtD
Triamterene—Dizziness—Imiquimod—skin cancer	0.000974	0.00855	CcSEcCtD
Triamterene—Thrombocytopenia—Dactinomycin—skin cancer	0.000955	0.00839	CcSEcCtD
Triamterene—Vomiting—Imiquimod—skin cancer	0.000936	0.00822	CcSEcCtD
Triamterene—Rash—Imiquimod—skin cancer	0.000928	0.00816	CcSEcCtD
Triamterene—Dermatitis—Imiquimod—skin cancer	0.000927	0.00815	CcSEcCtD
Triamterene—Headache—Imiquimod—skin cancer	0.000922	0.0081	CcSEcCtD
Triamterene—Dry mouth—Temozolomide—skin cancer	0.0009	0.00791	CcSEcCtD
Triamterene—Jaundice—Docetaxel—skin cancer	0.000897	0.00788	CcSEcCtD
Triamterene—Anaphylactic shock—Temozolomide—skin cancer	0.000882	0.00775	CcSEcCtD
Triamterene—Nausea—Imiquimod—skin cancer	0.000875	0.00768	CcSEcCtD
Triamterene—Thrombocytopenia—Temozolomide—skin cancer	0.000864	0.00759	CcSEcCtD
Triamterene—Fatigue—Dactinomycin—skin cancer	0.000841	0.00739	CcSEcCtD
Triamterene—Anaphylactic shock—Fluorouracil—skin cancer	0.000813	0.00714	CcSEcCtD
Triamterene—Thrombocytopenia—Fluorouracil—skin cancer	0.000796	0.00699	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—skin cancer	0.000771	0.00677	CcSEcCtD
Triamterene—Fatigue—Temozolomide—skin cancer	0.000761	0.00668	CcSEcCtD
Triamterene—Asthenia—Bleomycin—skin cancer	0.00075	0.00659	CcSEcCtD
Triamterene—Hypersensitivity—Dactinomycin—skin cancer	0.000719	0.00631	CcSEcCtD
Triamterene—Asthenia—Dactinomycin—skin cancer	0.0007	0.00615	CcSEcCtD
Triamterene—Diarrhoea—Dactinomycin—skin cancer	0.000667	0.00586	CcSEcCtD
Triamterene—Vomiting—Bleomycin—skin cancer	0.000665	0.00584	CcSEcCtD
Triamterene—Rash—Bleomycin—skin cancer	0.000659	0.00579	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—skin cancer	0.000659	0.00579	CcSEcCtD
Triamterene—Hypersensitivity—Temozolomide—skin cancer	0.00065	0.00571	CcSEcCtD
Triamterene—Asthenia—Temozolomide—skin cancer	0.000633	0.00556	CcSEcCtD
Triamterene—Nausea—Bleomycin—skin cancer	0.000621	0.00546	CcSEcCtD
Triamterene—Vomiting—Dactinomycin—skin cancer	0.00062	0.00545	CcSEcCtD
Triamterene—Rash—Dactinomycin—skin cancer	0.000615	0.0054	CcSEcCtD
Triamterene—Diarrhoea—Temozolomide—skin cancer	0.000604	0.0053	CcSEcCtD
Triamterene—Hypersensitivity—Fluorouracil—skin cancer	0.000599	0.00526	CcSEcCtD
Triamterene—Dry mouth—Docetaxel—skin cancer	0.000599	0.00526	CcSEcCtD
Triamterene—Anaphylactic shock—Docetaxel—skin cancer	0.000587	0.00515	CcSEcCtD
Triamterene—Dizziness—Temozolomide—skin cancer	0.000583	0.00513	CcSEcCtD
Triamterene—Nausea—Dactinomycin—skin cancer	0.000579	0.00509	CcSEcCtD
Triamterene—Thrombocytopenia—Docetaxel—skin cancer	0.000574	0.00505	CcSEcCtD
Triamterene—Vomiting—Temozolomide—skin cancer	0.000561	0.00493	CcSEcCtD
Triamterene—Rash—Temozolomide—skin cancer	0.000556	0.00489	CcSEcCtD
Triamterene—Diarrhoea—Fluorouracil—skin cancer	0.000556	0.00489	CcSEcCtD
Triamterene—Dermatitis—Temozolomide—skin cancer	0.000556	0.00488	CcSEcCtD
Triamterene—Headache—Temozolomide—skin cancer	0.000553	0.00486	CcSEcCtD
Triamterene—Dizziness—Fluorouracil—skin cancer	0.000538	0.00472	CcSEcCtD
Triamterene—Nausea—Temozolomide—skin cancer	0.000524	0.0046	CcSEcCtD
Triamterene—Vomiting—Fluorouracil—skin cancer	0.000517	0.00454	CcSEcCtD
Triamterene—Rash—Fluorouracil—skin cancer	0.000513	0.0045	CcSEcCtD
Triamterene—Dermatitis—Fluorouracil—skin cancer	0.000512	0.0045	CcSEcCtD
Triamterene—Headache—Fluorouracil—skin cancer	0.000509	0.00447	CcSEcCtD
Triamterene—Fatigue—Docetaxel—skin cancer	0.000506	0.00444	CcSEcCtD
Triamterene—Nausea—Fluorouracil—skin cancer	0.000483	0.00424	CcSEcCtD
Triamterene—Hypersensitivity—Docetaxel—skin cancer	0.000432	0.0038	CcSEcCtD
Triamterene—Asthenia—Docetaxel—skin cancer	0.000421	0.0037	CcSEcCtD
Triamterene—Diarrhoea—Docetaxel—skin cancer	0.000401	0.00353	CcSEcCtD
Triamterene—Dizziness—Docetaxel—skin cancer	0.000388	0.00341	CcSEcCtD
Triamterene—Vomiting—Docetaxel—skin cancer	0.000373	0.00328	CcSEcCtD
Triamterene—Rash—Docetaxel—skin cancer	0.00037	0.00325	CcSEcCtD
Triamterene—Dermatitis—Docetaxel—skin cancer	0.00037	0.00325	CcSEcCtD
Triamterene—Headache—Docetaxel—skin cancer	0.000368	0.00323	CcSEcCtD
Triamterene—Nausea—Docetaxel—skin cancer	0.000349	0.00306	CcSEcCtD
